Preoperative Radiochemotherapy in Rectal Cancer: Is There an Impact of Oxaliplatin on Pathologic Complete Response and Survival Rates under “Real World“ Conditions?

This study aimed to evaluate the benefit of additional administration of oxaliplatin during fluorouracil-based neoadjuvant radiochemotherapy (nRCT) in terms of pathologic complete remission (pCR), disease-free survival (DFS), and overall survival (OS) in patients with advanced rectal cancer. Between...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alexander Grabenbauer, Thomas Aigner, Holger Göbel, Bernhard J. Leibl, Christof Lamberti, Gerhard G. Grabenbauer, Luitpold V. Distel
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-01-01
coleção:	Cells
Assuntos:	locally advanced rectal cancer neoadjuvant radiochemotherapy oxaliplatin total neoadjuvant radiochemotherapy survival pathological complete remission
Acesso em linha:	https://www.mdpi.com/2073-4409/12/3/399
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!